WHO vs. FDA: How The Biologic Naming Plans Stack Up

Side-by-side chart compares World Health Organization's initial published proposal with the final version and FDA's August 2015 draft guidance on nonproprietary naming of biologic products.

More from Archive

More from Pink Sheet